Portfolio company
Metrion Biosciences
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This contract research organisation provides preclinical drug discovery and ion channel screening services to pharmaceutical and biotechnology companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MI Bioresearch
This contract research organisation provides preclinical oncology imaging and pharmacology services to pharmaceutical and biotechnology companies.
Clyde Biosciences
This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.
AIT Bioscience
This contract research organisation provides bioanalytical services and analytical method development to pharmaceutical and biotechnology companies for drug development and clinical trials.
WuXi Biology
This company provides drug discovery and preclinical development services to global pharmaceutical and biotechnology organisations.
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Precision for Medicine
This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.
BioAgilytix
This company provides bioanalytical testing services and contract research to pharmaceutical and biotechnology organisations developing large and small molecule therapeutics.
